DOJ Alleges Kaiser Defrauded Medicare Out of $1 Billion
DOJ Alleges Kaiser Defrauded Medicare Out of $1 Billion
Nov 23, 2021
policymed.com
Physician Payment Sunshine: Wall Street Journal and Forbes – Where is the Evidence For Patient Benefit?
Physician Payment Sunshine: Wall Street Journal and Forbes – Where is the Evidenc…
Jan 31, 2012
policymed.com
CMS Issues Final Rule on Managing Conflicts of Interests in Medicare Prescription Drug Decisions
CMS Issues Final Rule on Managing Conflicts of Interests in Medicare Prescription Drug …
Feb 12, 2015
policymed.com
Physician Payments Sunshine Act: Review of Individual State Reporting Requirements
Physician Payments Sunshine Act: Review of Individual State Reporting Requirements
Apr 3, 2014
policymed.com
Biden Administration Rescinds Trump Administration Insulin Pricing Rule
Biden Administration Rescinds Trump Administration Insulin Pricing Rule
Oct 26, 2021
policymed.com
IOM Clinical Practice Guidelines We Can Trust — But What About the IOM?
IOM Clinical Practice Guidelines We Can Trust — But What About the IOM?
Apr 11, 2011
policymed.com
Modern Medicine vs. Alternative Medicine: Different Levels of Evidence
Modern Medicine vs. Alternative Medicine: Different Levels of Evidence
Aug 19, 2011
policymed.com
Physician Payment Sunshine Act Final Rule: Research
Feb 6, 2013
policymed.com
Arthrex Reaches $16 Million Settlement Over Alleged False Claims Act Violations
Dec 6, 2021
policymed.com
Physician Payment Sunshine Act: Final Rule Top 50 Things to Know
Feb 5, 2013
policymed.com
A Tough Road: Cost To Develop One New Drug Is $2.6 Billion; Approval Rate for Drug…
Dec 2, 2014
policymed.com
GlaxoSmithKline (GSK) Settlement and Corporate Integrity Agreement
Jul 5, 2012
policymed.com
CMS Issues First Fines to Non-Compliant Hospitals Under Price Transparency Rules
Jul 28, 2022
policymed.com
Physician Payment Sunshine: French Sunshine Act and Disclosure Rules for Eur…
May 5, 2012
policymed.com
Physician Payment Sunshine Act Final Rule: Nature of Payment
Feb 8, 2013
policymed.com
FDA Draft Guidance Analgesic Indications: Developing Drug and Biological Products
Feb 28, 2014
policymed.com
Supreme Court Rules in Favor of Protecting Vaccine Makers from State Lawsuits
Mar 19, 2011
policymed.com
LabCorp Reaches $2.1 Million Settlement to Resolve False Claims Act Allegations
May 5, 2023
policymed.com
FDA ANDA Submissions Content and Format of Abbreviated New Drug Applications
Aug 18, 2014
policymed.com
Amgen Settlement and Corporate Integrity Agreement
Feb 21, 2013
policymed.com
FDA Draft Guidance on Expedited Programs for Serious Conditions – Drugs and Biologics
Jul 25, 2013
policymed.com
PhRMA Announces Updated Code on Interactions with Health Care Professional…
Aug 10, 2021
policymed.com
Walgreens Pays $500,000 Fine for Allegedly Violating CMP Law
Jan 21, 2022
policymed.com
American Medical Association House of Delegates Joins Prescription Drug Price De…
Nov 19, 2015
policymed.com
Critical Issues Affecting the Pharmaceutical Industry in 2012
Feb 5, 2012
policymed.com
FDA Issues Untitled Letter to Althera Over Roszet Promotions
Aug 24, 2022
policymed.com
HHS OIG Gives Green Light to Specific Free Drug Program
Apr 20, 2021
policymed.com
California Senate Passes Ban on “Gifts” to Physicians
May 22, 2017
policymed.com
CMS Issues Guidance Outlining Opportunities for Addressing Social Deter…
Jan 14, 2021
policymed.com
The Park Doctrine and FDCA Violations: Holding Corporate Executives Accountable
Dec 1, 2011
policymed.com
See more videos
Static thumbnail place holder
Feedback